Fox News senior medical analyst Dr. Marc Siegel reveals what he learned from his interview with National Institutes of Health ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, ...

The list seems to have been used as research for the 2024 book, "Toxic Shot: Facing the Dangers of the COVID 'Vaccines.'" The ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, joining multiple biotech companies that have lost government funding for their ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Trump officials are capitalizing on lingering COVID resentment to undermine American vaccine policy.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

Exosomes, naturally derived vesicles responsible for intercellular communication, are emerging as next-generation drug ...